The results affirm conclusions drawn by Bagli et al. [one], who carried out a analyze that incorporated 10 patients diagnosed with CRAO who been given HBOT. Besides getting 20 sessions of HBOT, oral acetazolamide and topical beta-blockers were being administered on the patients at the earliest feasible time.OPDIVO® (nivolumab) can be a prescriptio